Please assess the completion status of the following clinical trial:

Trial Title: Treximet ™ Pharmacy Budget Impact Model Database Validation Study

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: RETROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* At least one prescription claim for either Treximet ™ or orally administered triptan~* at least 18 years of age at index Rx date~* at least one prescription claim for any medication in the pre- and post-index period (proxy for continuous enrollment)~Exclusion Criteria:~* Subjects receiving nasal sumatriptan at any time~* Subjects over 65 years of age

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- adult migraineurs with/without aura (Type: None): Adult migraine patients \>18-65 years who have initiated treatment for migraine with Treximet ™ or other orally administered triptan.

Based on this trial design, predict the completion outcome and termination type (if applicable).